Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Abstract Introduction GLP-1 receptor agonists (GLP1-RAs) are increasingly prescribed as an alternative to bariatric surgery for weight loss, and may pose as an alternative to conversion Roux-En-Y Gastric Bypass (cRYGB) in patients with insufficient weight loss or weight recurrence after sleeve gastrectomy [A C, N C, A I
Common side effects include: Nausea Vomiting Diarrhea Constipation Stomach pain Headache Fatigue Injection site reactions These gastrointestinal symptoms are the most frequently reported, especially during the first few weeks or after dose increases
Vomiting : This may occur alongside nausea, particularly in the early stages of use
Semaglutide is a medication that has been used primarily for managing type 2 diabetes and assisting with weight loss
US$ 22.24
US$ 24.89
US$ 23.64
US$ 22.56
